Skip to main content

Technology for entertainment

I'm passing this info along to anyone who might be interested:

SAVE THE DATE







Thursday, May 26, 2011














The Computer Center for Visually Impaired People (CCVIP) at Baruch College Invites You to a Technology Demonstration Entitled:
For Entertainment Purposes Only




NEW Times: *1:00-3:00pm or 6:00-8:00pm




Where: Baruch College 151 East 25th Street, Room 763




What: In this session, we will be exploring devices and software that are strictly for “Entertainment Purposes”. We will focus on Apple TV, a television top box that brings access to movies, television, music and more to people who are blind or partially sighted with its built in Voiceover screen reading technology. Have you ever been frustrated at not being able to order your own pay-per-view movie on your cable system? If so, Apple TV might be the right device for you. In addition to Apple TV, we will be showcasing accessible apps and products that give us access to radio stations, NetFlix and even some gaming options.




Admission: Free




Reservations Required: Call 646-312-1420
If you are unable to join us in person, the presentation will be recorded and posted on our site for viewing at your convenience. Please visit us at: www.baruch.cuny.edu/ccvip




Also mark your calendars for Thursday, July 28, 2011, when we will be offering our next Demo Center Presentation. Have you ever gone to buy a home appliance? What was that like for you—were the stores able to accommodate you? Are the appliances all that they could be, or do they just fail to meet your needs? Brad Hodges, from the American Foundation for the Blind’s Tech Center will talk to us about the adventure that is home appliance shopping.










Thank you!






Lisa F. Saunders


646-312-1420


lisa.saunders@baruch.cuny.edu






Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more